News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
221,456 Results
Type
Article (4982)
Company Profile (22)
Press Release (216452)
Section
Business (82178)
Career Advice (461)
Deals (15039)
Drug Delivery (8)
Drug Development (19053)
Employer Resources (30)
FDA (3672)
Job Trends (3896)
News (120071)
Policy (7498)
Tag
Academia (290)
Alliances (14696)
Alzheimer's disease (215)
Approvals (3667)
Bankruptcy (94)
Best Places to Work (2848)
Biotechnology (24)
Breast cancer (21)
Cancer (240)
Career advice (391)
Cell therapy (54)
Clinical research (15678)
Collaboration (83)
Compensation (65)
COVID-19 (293)
C-suite (46)
Data (286)
Diabetes (24)
Diagnostics (1996)
Earnings (39981)
Employer resources (31)
Events (36944)
Executive appointments (135)
FDA (3782)
Funding (90)
Gene therapy (25)
GLP-1 (97)
Government (406)
Healthcare (4998)
Infectious disease (304)
Inflammatory bowel disease (22)
Interviews (53)
IPO (7734)
Job creations (1120)
Job search strategy (360)
Layoffs (95)
Legal (2322)
Lung cancer (26)
Manufacturing (28)
Medical device (3816)
Medtech (3817)
Mergers & acquisitions (7343)
Metabolic disorders (74)
Neuroscience (260)
NextGen Class of 2024 (1671)
Non-profit (724)
Northern California (528)
Obesity (36)
Opinion (28)
People (24166)
Phase I (4672)
Phase II (6816)
Phase III (5409)
Pipeline (261)
Postmarket research (625)
Preclinical (1832)
Press Release (66)
Radiopharmaceuticals (103)
Rare diseases (38)
Real estate (1868)
Regulatory (4981)
Research institute (298)
Resumes & cover letters (68)
Southern California (400)
Startups (1006)
United States (4209)
Vaccines (25)
Date
Today (31)
Last 7 days (210)
Last 30 days (1283)
Last 365 days (11124)
2024 (10300)
2023 (13193)
2022 (18658)
2021 (19679)
2020 (18239)
2019 (13205)
2018 (10205)
2017 (10001)
2016 (9156)
2015 (12120)
2014 (9587)
2013 (7707)
2012 (8330)
2011 (8796)
2010 (8634)
Location
Africa (182)
Arizona (49)
Asia (11284)
Australia (1557)
California (1076)
Canada (454)
China (29)
Colorado (41)
Connecticut (55)
Europe (23963)
Florida (139)
Georgia (22)
Idaho (23)
Illinois (75)
Indiana (35)
Japan (30)
Kansas (23)
Maine (34)
Maryland (138)
Massachusetts (896)
Michigan (60)
Minnesota (98)
New Jersey (336)
New York (298)
North Carolina (239)
Northern California (528)
Ohio (36)
Pennsylvania (226)
South America (273)
Southern California (400)
Texas (126)
Utah (31)
Washington State (98)
221,456 Results for "genelux corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
November 7, 2024
·
1 min read
Biotech Beach
Genelux Corporation Announces Proposed Public Offering of Common Stock and Warrants
Genelux Corporation, a late clinical-stage immuno-oncology company, announced that it has commenced an underwritten public offering of its common stock and accompanying warrants.
May 23, 2024
·
4 min read
Press Releases
Genelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business Updates
November 15, 2024
·
8 min read
Press Releases
Genelux Corporation to Participate in the 2024 Maxim Healthcare Virtual Summit
October 10, 2024
·
1 min read
Business
Genelux Corporation Reports First Quarter 2024 Financial Results and Provides General Business Updates
Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today announced financial results for the first quarter of 2024 and provided general business updates.
May 9, 2024
·
8 min read
Biotech Beach
Genelux Corporation Announces Pricing of Approximately $27.5 Million Underwritten Offering of Common Stock and Accompanying Warrants
Genelux Corporation announced the pricing of an underwritten offering of 6,875,000 shares of its common stock and accompanying warrants to purchase 6,875,000 shares of its common stock at a combined offering price of $4.00 per share and accompanying warrant, in each case before underwriting discounts and commissions.
May 24, 2024
·
4 min read
Business
Genelux Corporation to Present at the H.C. Wainwright Global Investment Conference
September 3, 2024
·
1 min read
Business
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, reported fourth quarter and full year 2023 financial results and business updates.
April 1, 2024
·
9 min read
Press Releases
Genelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung Cancer
October 22, 2024
·
4 min read
Press Releases
Genelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business Updates
August 15, 2024
·
8 min read
1 of 22,146
Next
